In Brief: Genentech's Activase
Executive Summary
Genentech's Activase: On June 6 the Peripheral & CNS committee will consider tPA (PLA 96-035) for management of acute ischemic stroke in adults for improving functional and neurological recovery and reducing the incidence of disability associated with stroke...